Cambrex

Acquired

CDMO | Drug Substance, Drug Product & Analytical Services

Cambrex is a biotech company in East Rutherford, United States, founded in 1981.

Employees
1001–5000
Founded
1981
Business Model
B2B
Acquisition Date
Aug 2019

About

Cambrex is a leading global contract development and manufacturing organization (CDMO) providing end-to-end services across the entire pharmaceutical drug lifecycle. Founded in 1981 and headquartered in East Rutherford, New Jersey, Cambrex operates a global network of 14 locations across North America and Europe, employing a team of more than 2,000 scientists and manufacturing specialists. The company's core offerings span drug substance development and manufacturing — including custom API development, custom API manufacturing, generic API manufacturing (with over 70 approved generic APIs), and peptide development and manufacturing — as well as comprehensive drug product and analytical services covering method development, stability testing, microbiology, solid state chemistry, and formulation development. Cambrex's generic API manufacturing practice draws on more than 40 years of experience, with production sites in Italy, Sweden, and the USA. The company serves pharmaceutical and biotech customers from preclinical through commercial stages, positioning itself as a creative problem-solving partner that combines deep scientific expertise with a collaborative, customer-centric culture.

Exit History

Data from Indexed.vcUpdated
AcquisitionAug 2019

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×4
  • Backend ×1
  • DevOps ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cambrex on Indexed.vc
<a href="https://indexed.vc/companies/cambrex"><img src="https://indexed.vc/api/badge/company/cambrex" alt="Cambrex on Indexed.vc" width="260" height="76" /></a>